Prevention of ANThracycline‐Induced Cardiac dysfunction by dexrazoxane In PATients with diffusE large B‐cell lymphoma: a prospective randomized trial
Medicine
Population
ASCVD
Phase
III
Starting year
2024
Publications: ANTICIPATE
Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: preventing anthracycline-induced cardiac dysfunction with dexrazoxaneCardio-oncology-Abstract-Schut, drs. A.-ANTICIPATE-ASCVD